| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.002 | 1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |